Comments*

 
  • From the Editors

    Welcome to the reappraisal of the European guidelines on hypertension management – now available to ESH members!

    By Krzysztof Narkiewicz, Peter Nilsson and Mark Caulfield



    It is a major task to work on joint European guidelines on the detection, diagnosis and management of hypertension. This manifested itself in the 2007 version of the joint European Society of Hypertension (ESH) / European Society of Cardiology (ESC) Guidelines on hypertension [1]. These guidelines are going to be revised in full in the future, building upon an agreement between the two societies, but just recently a task force of the ESH published what is called a reappraisal of European guidelines on hypertension [2].

  • Letter from the new ESH President

    Dear Colleagues,

    I am extremely grateful for the honor of being nominated as your next president. The strength and potency of our society, the European Society of Hypertension, is the direct result of the dedication of its members and officers. To be the president of this fine organization requires a never-ending commitment and a strong sense of duty. We have all been fortunate enough to witness these capabilities by the performance of Stephane Laurent, and that of his predecessor, Sverre Kjeldsen. I had the good fortune to serve as general secretary under both of them. They have demonstrated a standard of excellence in the performance of their duties, which your next president can only hope to maintain and carry forward as our society continues to grow.

    Let me take the opportunity to speak for all the members of the ESH attending the 2009 annual meeting, and direct a big "Thank you" to our Prof. Giuseppe Mancia and other members of the Organizing Committee in Milan.

    Even though we will all go our separate ways after the Milan meeting, our work together will go on as always. To facilitate this, I will keep the lines of communications, including the new ESH portal, open and buzzing. You will hear from me and other ESH Council members from time to time when important issues arise which concern the progress and well-being of our vibrant, growing society. And of course, our eyes and ears will be open to any input coming from all ESH members.

    I wish each and everyone of you success in the coming weeks and months in all your efforts. Now, let us part ways for the time being thinking ahead to the annual meeting in Oslo next year.

    Krzysztof Narkiewicz
    ESH President

  • What's New

    Enter the New Portal!

    Welcome to ESH's new portal - the universe of information for hypertension professionals - completely replacing the former ESH website. The transformed home page of the European Society of Hypertension has been designed to provide you with optimal access to the clinical, scientific, news and educational tools you need to individualize therapy for your patients.  
     
    We hope you'll enjoy the user-friendly menus, Google-powered search, improved navigation, E-mail, readability options and print tools. We want you to find relevant content faster, locate colleagues, sort specialists by country, and enhance your interactive web experience in an environment where timely information translates to clinical excellence. 

    We would also like to take this opportunity to invite all ESH members to update their personal information on the portal. Please log in to edit your membership profile.

    Krzysztof Narkiewicz                                      
    Portal Co-Editor                                         
    President, European Society of Hypertension

    Peter M. Nilsson                                      
    Portal Co-Editor 
    Secretary, 
    European Society of Hypertension

  • Interactive Poll Question

    ACCOMPLISH Trial

    In the recently published ACCOMPLISH trial the combination of and ACE-inhibitor (ACE-I) with a calcium antagonist (CaA) was 20% more effective than the combination of ACE-I with a thiazide diuretic. Will this finding, in hypertensive patients of mixed ethnical background and risk levels, change your own practice in relation to your patients? Will you prescribe the first combination (ACE-I + CaA) more than before from now on?
    Yes
    No
      Results